Association of Midlife Plasma Amyloid-β Levels With Cognitive Impairment in Late Life: The ARIC Neurocognitive Study.
Kevin J SullivanChad BlackshearJeannette SiminoAdrienne TinKeenan A WalkerA Richey SharrettSteven G YounkinRebecca F GottesmanMichelle M MielkeDavid KnopmanB Gwen WindhamMichael E GriswoldThomas H MosleyPublished in: Neurology (2021)
Midlife measurement of plasma Aβ may have utility as a blood-based biomarker indicative of risk for future cognitive impairment.
Keyphrases